Sponsor pipeline

Alfasigma S.p.A. clinical trial pipeline

Get alerts when Alfasigma S.p.A.'s trials change

6 active trials 3 recruiting 4 Phase 3 3 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-18
Trial completed
NCT02914535 Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis · Phase 3

Active trials by phase

Phase 3
4
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06865417 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative… Ulcerative Colitis Recruiting 2026-08-12
NCT07553182 OLE Study With Filgotinib in JIA Juvenile Idiopathic Arthritis (JIA) Recruiting 2026-08-10
NCT07554495 Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of… Polyarticular Course Juvenile Idiopathic Arthritis Recruiting 2026-06-12
NCT05785611 A Study Evaluating the Effect of Filgotinib in Participants With Active Axial… Axial Spondyloarthritis Active, Not Recruiting 2025-12-04
Not specified
NCT05817942 Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants… Ulcerative Colitis Active, Not Recruiting 2025-12-24
NCT04871919 Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis Active, Not Recruiting 2025-09-15

Disease areas by active trials

Ulcerative Colitis (2) · Ankylosing Spondylitis (1) · Rheumatoid Arthritis (1)

Get alerts when Alfasigma S.p.A.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free